369 related articles for article (PubMed ID: 34831357)
1. Hedgehog Pathway Inhibitors against Tumor Microenvironment.
Gampala S; Yang JY
Cells; 2021 Nov; 10(11):. PubMed ID: 34831357
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications.
Grund-Gröschke S; Stockmaier G; Aberger F
Cell Commun Signal; 2019 Dec; 17(1):172. PubMed ID: 31878932
[TBL] [Abstract][Full Text] [Related]
3. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.
Katoh M
Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756
[TBL] [Abstract][Full Text] [Related]
4. M2 macrophage-derived IL6 mediates resistance of breast cancer cells to hedgehog inhibition.
Xu X; Ye J; Huang C; Yan Y; Li J
Toxicol Appl Pharmacol; 2019 Feb; 364():77-82. PubMed ID: 30578886
[TBL] [Abstract][Full Text] [Related]
5. Hedgehog signaling pathway inhibitors: an updated patent review (2015-present).
Quaglio D; Infante P; Di Marcotullio L; Botta B; Mori M
Expert Opin Ther Pat; 2020 Apr; 30(4):235-250. PubMed ID: 32070165
[No Abstract] [Full Text] [Related]
6. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog inhibitors: a patent review (2013 - present).
Xin M
Expert Opin Ther Pat; 2015 May; 25(5):549-65. PubMed ID: 25726713
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog inhibition as an anti-cancer strategy.
Raju GP; Pham D
Vitam Horm; 2012; 88():507-22. PubMed ID: 22391319
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment.
Zhang J; Fan J; Zeng X; Nie M; Luan J; Wang Y; Ju D; Yin K
Acta Pharm Sin B; 2021 Mar; 11(3):609-620. PubMed ID: 33777671
[TBL] [Abstract][Full Text] [Related]
10. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
Queiroz KC; Spek CA; Peppelenbosch MP
Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Hedgehog signaling in the gastrointestinal tract: targeting the cancer microenvironment.
Merchant JL; Saqui-Salces M
Cancer Treat Rev; 2014 Feb; 40(1):12-21. PubMed ID: 24007940
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Hedgehog Antagonists for Cancer Therapy.
Khatra H; Bose C; Sinha S
Curr Med Chem; 2017; 24(19):2033-2058. PubMed ID: 28302010
[TBL] [Abstract][Full Text] [Related]
13. Nonclassical hedgehog-GLI signaling and its clinical implications.
Shevde LA; Samant RS
Int J Cancer; 2014 Jul; 135(1):1-6. PubMed ID: 23929208
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
Rovida E; Stecca B
Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway.
Beauchamp EM; Ringer L; Bulut G; Sajwan KP; Hall MD; Lee YC; Peaceman D; Ozdemirli M; Rodriguez O; Macdonald TJ; Albanese C; Toretsky JA; Uren A
J Clin Invest; 2011 Jan; 121(1):148-60. PubMed ID: 21183792
[TBL] [Abstract][Full Text] [Related]
16. Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.
Hack SP; Zhu AX; Wang Y
Front Immunol; 2020; 11():598877. PubMed ID: 33250900
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer.
Onishi H; Katano M
World J Gastroenterol; 2014 Mar; 20(9):2335-42. PubMed ID: 24605030
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the design of Hedgehog pathway inhibitors for the treatment of malignancies.
Banerjee U; Hadden MK
Expert Opin Drug Discov; 2014 Jul; 9(7):751-71. PubMed ID: 24850423
[TBL] [Abstract][Full Text] [Related]
19. Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity.
Grund-Gröschke S; Ortner D; Szenes-Nagy AB; Zaborsky N; Weiss R; Neureiter D; Wipplinger M; Risch A; Hammerl P; Greil R; Sibilia M; Gratz IK; Stoitzner P; Aberger F
Mol Oncol; 2020 Sep; 14(9):1930-1946. PubMed ID: 32615027
[TBL] [Abstract][Full Text] [Related]
20. Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance.
Gruber W; Peer E; Elmer DP; Sternberg C; Tesanovic S; Del Burgo P; Coni S; Canettieri G; Neureiter D; Bartz R; Kohlhof H; Vitt D; Aberger F
Int J Cancer; 2018 Mar; 142(5):968-975. PubMed ID: 29055107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
